Want to see JP:7681 full AI Analyst Report?

LEOCLAN Co. Ltd. (7681) Price & Analysis

0 Followers

7681 Stock Chart & Stats

¥999.00

¥0.00(0.00%)

At close: Jan 08 4:00 PM EST

¥999.00

¥0.00(0.00%)

Day’s Range― - ―

52-Week Range¥725.00 - ¥1,190.00

Previous CloseN/A

Volume200.00

Average Volume (3M)2.82K

Market Cap

¥5.98B

Enterprise Value¥1.64K

Total Cash (Recent Filing)¥8.78B

Total Debt (Recent Filing)¥4.90B

Price to Earnings (P/E)51.7

Beta-0.23

Next Earnings

Nov 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.68%

Share Statistics

EPS (TTM)19.53

Shares Outstanding5,922,000

10 Day Avg. Volume3,320

30 Day Avg. Volume2,816

Financial Highlights & Ratios

PEG Ratio3.64

Price to Book (P/B)1.18

Price to Sales (P/S)0.31

P/FCF Ratio-57.01

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Near-zero LeverageA debt-free balance sheet reduces refinancing and interest-rate risk, giving LEOCLAN greater resilience through operating volatility. Stable equity also supports the asset base and preserves financial flexibility for investment or working-capital needs.

2025 Revenue ReboundThe sharp 2025 revenue recovery indicates that demand and distribution activity can rebound materially after weakness. If supported by repeat customer and supplier relationships, this provides a foundation for restoring scale and improving earnings power.

Still ProfitableContinued profitability, even with compressed margins, shows the core distribution model remains economically viable. The modest operating-margin improvement offers a base for earnings recovery if revenue becomes more consistent and cost discipline is maintained.

Bears Say

Weak Cash ConversionRecent negative operating and free cash flow means reported profits are not consistently converting into cash. Persistent working-capital swings or investment needs could constrain reinvestment, reduce financial flexibility, and weaken the quality of earnings.

Thin ProfitabilityVery slim net margins leave limited protection against supplier costs, logistics expenses, or pricing pressure. The decline from earlier margin levels suggests profitability has not yet demonstrated durable improvement despite the 2025 revenue rebound.

Lower Returns On EquityFalling returns on equity indicate that the company is generating less profit from its capital base. This weakens the economic productivity of its conservative balance sheet and may signal challenges in sustaining attractive shareholder returns.

7681 FAQ

What was LEOCLAN Co. Ltd.’s price range in the past 12 months?

LEOCLAN Co. Ltd. lowest stock price was ¥725.00 and its highest was ¥1190.00 in the past 12 months.

What is LEOCLAN Co. Ltd.’s market cap?

LEOCLAN Co. Ltd.’s market cap is ¥5.98B.

When is LEOCLAN Co. Ltd.’s upcoming earnings report date?

LEOCLAN Co. Ltd.’s upcoming earnings report date is Nov 13, 2026 which is in 50 days.

How were LEOCLAN Co. Ltd.’s earnings last quarter?

LEOCLAN Co. Ltd. released its earnings results on Aug 07, 2026. The company reported ¥7.56 earnings per share for the quarter.

Is LEOCLAN Co. Ltd. overvalued?

According to Wall Street analysts LEOCLAN Co. Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LEOCLAN Co. Ltd. pay dividends?

LEOCLAN Co. Ltd. pays a Annually dividend of ¥17 which represents an annual dividend yield of 1.68%. See more information on LEOCLAN Co. Ltd. dividends here

What is LEOCLAN Co. Ltd.’s EPS estimate?

LEOCLAN Co. Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LEOCLAN Co. Ltd. have?

LEOCLAN Co. Ltd. has 5,922,000 shares outstanding.

What happened to LEOCLAN Co. Ltd.’s price movement after its last earnings report?

LEOCLAN Co. Ltd. reported an EPS of ¥7.56 in its last earnings report. Following the earnings report the stock price went down -0.103%.

Which hedge fund is a major shareholder of LEOCLAN Co. Ltd.?

Currently, no hedge funds are holding shares in JP:7681

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

LEOCLAN Co. Ltd.

LEOCLAN Co.,Ltd. operates as a medical equipment trading firm, addressing diverse needs across medical care, welfare, and general health sectors. Its operations are structured into three main divisions: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment delivers comprehensive services. This includes advisory support for selecting medical equipment, subsequent maintenance, and undertaking interior design, construction, and installation projects for medical facilities, preventive health centers, and nursing care institutions. Additionally, this segment is involved in the sale of medical devices and information systems. Through its Remote Image Diagnosis Service Business, the company facilitates the remote interpretation of imaging data from MRI, CT, and other scans by diagnostic radiology specialists, subsequently providing critical diagnostic information. Finally, the School Lunch Business segment offers a variety of meal services—including regular, therapeutic, and other specialized dietary options—to nursing care and welfare facilities. Established in 2001, LEOCLAN Co.,Ltd. is headquartered in Settsu, Japan.